
During the last two decades, the outcome of various gene therapy protocols lead to medical community disbelief. Nevertheless, successful results obtained in recent years, repositioned gene therapy as a promising option for treatment of several diseases. Facing this renaissance of the international scientific community interest on gene therapy, it seems to be necessary for the generalist physician to understand its strength and limitations. The objective of this article is to comment the way gene therapy addresses nowadays the treatment of such different pathologies as neoplasias, infections and monogenic diseases.

